European Immunotherapy Net

The central resource platform for healthcare professionals and patients, giving you the latest news and updates on all areas of immunotherapy.


European Immunotherapy Net

The European Immunotherapy Net brings you the latest news and updates on all areas of immunotherapy. This platform offers healthcare professionals, nurses and patients access to the best in scientific publications, research, continuing medical education and more via a digital community that nurtures a transparent exchange of ideas, information, and activities. Powered by the European Hematology Association.

Learn More

Featured: Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?

Browse all scientific publications

Latest News

Onclive8

Immunotherapy Inches Forward in Development of Myeloid Malignancies

Amer Zeidan, MD, MHS, discusses how survival for patients with acute myeloid leukemia and myelodysplastic syndrome remains poor, and although immunotherapy has been positioned as a holy grail, it would be preemptive to predict its future based on the number of small studies that have been performed to date.

Onclive9

Stadtmauer Spotlights the Explosion of BCMA-Directed Therapies in Multiple Myeloma

Edward A. Stadtmauer, MD, highlights the emergence of several BCMA-directed therapies, such as monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies, and how outcomes for patients with multiple myeloma have improved significantly.

vjhemonic11

Effect of BMT status on decitabine plus ipilimumab in R/R MDS/AML

Jacqueline Garcia, MD, Dana-Farber Cancer Institute, Boston, MA, presents the safety and clinical activity data from a Phase I study (NCT02890329) of decitabine (DAC) plus ipilimumab (IPI) in patients with relapsed/refractory (R/R) myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in the post bone marrow transplant (BMT) or treatment naïve setting.

Contributions

European Immunotherapy Net: Together, we can make a difference.

At European Immunotherapy Net, we believe that working together is the key to driving positive change, and that is why we are asking you to join us. Let's work together in creating a dedicated immunotherapy resource platform that represents the highest level of professional knowledge, ultimately helping to provide the best care for patients. Learn more about how you can contribute.

 

Research Highlights

ImmunotherapyWebsite Nurses Patients 99

Scientific Publications

Browse our collection of scientific publications on Immunotherapy to learn more about the latest research and developments in the field.

Read more
Immunotherapy Web Featured Images 30

Grants

EHA Research Grants support talented junior researchers in advancing their career, e.g. towards becoming the leader of a research group. If you have ambition for advancing your career and you have the support of your department and institute, learn more about EHA's research grants.

Visit website
Education Higlights

Immunotherapy Web Featured Images 38

CAR-T Course: Regulatory Aspects of Immunotherapy

The latest course in the EHA CAR-T Program is now available: Regulatory Aspects of Immunotherapy. This course explores the regulatory processes for evaluation and authorization of medicines in the EU, with a special focus on innovative and biologic drugs. The pathways of regular and accelerated marketing authorizations and post-marketing surveillance are also covered.

Visit website
Immunotherapy Web Featured Images 88

CAR-T cell therapy in the real world (EHA25 Virtual)

Managing complex CAR-T cell treatments in the clinical practice may be challenging, however, several real-world data are currently available. Listen to Catherine Thieblemont discussing the main issues of CAR-T therapy delivery and results in the real life during the past EHA25 Virtual congress.

Read more
Patient Highlights

ImmunotherapyWebsite Nurses Patients 34

Pediatrics

Whether you are a health care practitioner looking to expand your knowledge or a carer explaining immunotherapy to a child or its family for the first time, we are here to help. Explore the resource library for an overview of resources relating to pediatric patients.

Access resource library
ImmunotherapyWebsite Nurses Patients 33

Adults

While Immunotherapy has the power to change lives, it can be hard to find the information and support you need during treatment. Get an overview of the best information that will help you to understand your treatment, and direct you to the support you need by exploring the resource library.

Acess resource library
Nurses Highlights

Immunotherapy Web Featured Images 41

The role of the coordinator nurse in the CAR-T treatment

In this video, Marlene Vercasson, from the Lyon Hospital, shares her experience in the local CAR-T program and Juliet international clinical trial.

Read more
Immunotherapy Web Featured Images 51

Do mAbs and paraprotein affect COVID-19 Serological Testing in Patients with Multiple Myeloma?

SARS-CoV-2 (COVID-19) serology tests do not appear to interfere or cause cross-reactivity with therapeutic monoclonal antibody (t-mAb) treatments for hematologic malignancies (HM) such as multiple myeloma (MM), according to a study published in Diagnostics.

Read more